MoneyWorks4Me

Aurobindo Pharma informs about press release

09 Dec 2020 Evaluate

Aurobindo Pharma has informed that it has enclosed a copy of the Press Release on 9th December 2020 that is being issued by the Company in connection with USFDA approval received by the Company for Dexmedetomidine HCL in 0.9% Sodium Chloride Injection.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1752.50
Dr. Reddys Labs. 1180.00
Cipla 1305.00
Lupin 1942.00
Zydus Lifesciences 1115.20
View more..